Details for Selection
| Standard label: | Prescription Drug Benefit, Effect of Subsidy on Net Periodic Postretirement Benefit Cost |
| Name: | us-gaap:PrescriptionDrugBenefitEffectOfSubsidyOnNetPeriodicPostretirementBenefitCost |
| Documentation: | Amount of the effect of the government subsidy for prescription drug benefits on the measurement of net periodic postretirement benefit cost for the current period. That effect includes (1) any amortization of the actuarial experience gain, (2) the reduction in current period service cost due to the subsidy, and (3) the resulting reduction in interest cost on the accumulated postretirement benefit obligation as a result of the subsidy. Disclosure relates to the first period in which an employer includes the effects of the subsidy in measuring the accumulated postretirement benefit obligation and net periodic postretirement benefit cost. |
| Commentary: | |
| Data type: | Monetary (xbrli:monetaryItemType) |
| Period type: | As of (instant) |
| Balance type: | Debit |
| Object class: | [Concept] |